Healthcare Focus · Life Sciences & Pharma
Meetings with life sciences buyers.
Connexu schedules meetings with the pharma and life sciences leaders who decide on digital health partnerships, companion apps, real-world evidence, and patient engagement platforms.
920+
Meetings booked with healthcare buyers
7 days
From kickoff to first qualified meeting
$27.2M+
Pipeline generated for clients
100%
Healthcare-specialized SDRs
Who We Book Meetings With
The life sciences buyers we put on your calendar.
Pharma buying decisions are complex and partnership-driven. We map the stakeholders across digital health, medical affairs, and commercial teams — and engage them with evidence-led, partnership-framed outreach.
VP Digital Health & Innovation
Owns the digital roadmap and evaluates companion apps, digital therapeutics, and platform partnerships. Looking for proven solutions that extend their product's reach.
VP Clinical Innovation
Explores novel endpoints, real-world evidence, and digital biomarkers. Needs clinical rigor and regulatory credibility.
Medical Affairs / Medical Directors
Clinical evidence, scientific credibility, and KOL engagement. They evaluate whether a partnership is scientifically sound.
VP Patient Engagement
Adherence tools, patient support programs, and digital touchpoints across the patient journey. Focused on outcomes and retention.
HEOR / Real-World Evidence Leads
Health economics, outcomes data, and real-world evidence generation. They need data partnerships that demonstrate value.
Brand / Commercial Leads
Market access, differentiation, and commercial impact. They evaluate whether a partnership drives market share and brand value.
How Connexu Schedules Meetings
How Connexu schedules meetings with life sciences buyers.
Map the pharma org structure
Life sciences companies are matrixed. We map the relevant stakeholders across digital health, medical affairs, clinical innovation, and commercial teams — so outreach reaches the people who can actually initiate a partnership, not a general inbox.
Lead with evidence and real-world data
Pharma buyers are trained to evaluate evidence. Every outreach references clinical data, real-world evidence, or published outcomes. We frame your solution as scientifically credible — not a vendor pitch.
Frame outreach as partnership, not procurement
Life sciences deals are often partnerships, not purchases. We position your platform as a strategic collaboration — companion app, evidence generation, or patient engagement initiative — that aligns with their therapeutic area priorities.
Target by therapeutic area and pipeline
We use intent signals and pipeline intelligence to identify pharma companies actively investing in your therapeutic area or capability — clinical trial announcements, pipeline updates, and partnership news — so outreach is timely and relevant.
Navigate regulatory and compliance constraints
Pharma outreach is constrained by regulatory and compliance rules. Our SDRs understand the boundaries — no off-label claims, no inappropriate promotional language — so outreach builds credibility without creating compliance risk.
Engage KOL-aware cadences
Many pharma decisions involve key opinion leaders and scientific advisory input. We design cadences that reference relevant KOL perspectives, conference data, and peer-reviewed evidence — so outreach resonates with scientifically-minded buyers.
The Challenges We Solve
Why booking meetings in life sciences is hard — and how we make it work.
Matrixed buying committees
Pharma decisions span digital health, medical affairs, commercial, and HEOR teams — often across global and regional layers. We map the matrix and engage multiple stakeholders so partnerships don't die in a single thread.
Long partnership cycles
Life sciences deals are structured as partnerships and can take 12–18 months. We keep momentum with sustained, evidence-led cadences — so your partnership stays on the agenda between meetings.
Regulatory and compliance constraints
Pharma outreach must navigate FDA, off-label, and internal compliance rules. Our SDRs understand these boundaries — so outreach is credible and compliant, not a compliance liability.
Access to the right stakeholders
Pharma innovation leaders are insulated behind layers of gatekeepers. Our multi-channel persistence — email, phone, LinkedIn — breaks through to the people who can actually initiate a partnership.
Why Connexu
Healthcare-specialized SDRs who speak your buyers' language.
Pharma fluency
Our SDRs understand therapeutic areas, pipeline dynamics, HEOR, and regulatory constraints — so they speak the language of pharma buyers from the first touch.
Partnership-framed outreach
We position your platform as a strategic collaboration, not a vendor transaction — which is how life sciences buyers actually evaluate and buy.
Pipeline in 7 days
A managed team is fully ramped and booking qualified meetings in 7 days — not the months it takes to hire and train SDRs who understand pharma.
FAQs
Frequently Asked Questions
How does Connexu book meetings with life sciences and pharma buyers?
We map the matrixed pharma org to find the right stakeholders — VP Digital Health, Medical Affairs, Clinical Innovation, HEOR, and commercial leads — then frame outreach as a strategic partnership backed by clinical evidence. Our SDRs understand regulatory boundaries so outreach is credible and compliant.
Which life sciences decision-makers can you reach?
We engage VP Digital Health & Innovation, VP Clinical Innovation, Medical Affairs directors, VP Patient Engagement, HEOR / real-world evidence leads, and brand / commercial leads. We map the full committee across therapeutic areas and pipeline priorities.
How fast can you start booking meetings?
Our managed SDR teams are fully ramped and booking qualified meetings within 7 days of kickoff. Our healthcare-specialized reps understand pharma buying processes, evidence requirements, and compliance constraints from day one.
Keep exploring
More from Connexu.
Explore the platform
The AI SDR Co-Pilot and managed SDR teams behind these meetings.
Managed vs. in-house
Why a managed SDR engine costs a fraction of building it yourself.
Client results
$32.1M+ in pipeline generated in 2026 and 1,663 meetings across healthcare clients.
HIPAA-compliant SDR outreach
How to run healthcare outreach that's both compliant and effective.
Selling to health system CMOs
What actually gets a CMO to reply — and what gets archived.
MedTech go-to-market playbook
From FDA clearance to first meetings in 90 days.
Put life sciences buyers on your calendar.
Book a demo and see how Connexu's healthcare-specialized SDRs book meetings with pharma digital health, medical affairs, and patient engagement leaders — framing your platform as the partnership they're looking for.
Book a demo